GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zealand Pharma A/S (CHIX:ZEALc) » Definitions » E10

Zealand Pharma A/S (CHIX:ZEALC) E10 : kr-12.42 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Zealand Pharma A/S E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Zealand Pharma A/S's adjusted earnings per share data for the three months ended in Mar. 2024 was kr-3.710. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-12.42 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was -30.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Zealand Pharma A/S was -30.20% per year. The lowest was -43.80% per year. And the median was -37.00% per year.

As of today (2024-06-05), Zealand Pharma A/S's current stock price is kr628.50. Zealand Pharma A/S's E10 for the quarter that ended in Mar. 2024 was kr-12.42. Zealand Pharma A/S's Shiller PE Ratio of today is .


Zealand Pharma A/S E10 Historical Data

The historical data trend for Zealand Pharma A/S's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zealand Pharma A/S E10 Chart

Zealand Pharma A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.81 -5.33 -8.15 -11.38 -11.31

Zealand Pharma A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.54 -11.75 -9.68 -11.31 -12.42

Competitive Comparison of Zealand Pharma A/S's E10

For the Biotechnology subindustry, Zealand Pharma A/S's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zealand Pharma A/S's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zealand Pharma A/S's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zealand Pharma A/S's Shiller PE Ratio falls into.



Zealand Pharma A/S E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zealand Pharma A/S's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-3.71/118.4000*118.4000
=-3.710

Current CPI (Mar. 2024) = 118.4000.

Zealand Pharma A/S Quarterly Data

per share eps CPI Adj_EPS
201406 -2.110 99.700 -2.506
201409 0.740 99.700 0.879
201412 -2.780 99.400 -3.311
201503 -2.450 100.200 -2.895
201506 -3.400 100.300 -4.014
201509 -2.210 100.200 -2.611
201512 3.050 99.800 3.618
201603 -3.270 100.200 -3.864
201606 -4.100 100.600 -4.825
201609 -1.290 100.200 -1.524
201612 2.180 100.300 2.573
201703 -1.030 101.200 -1.205
201706 -3.690 101.200 -4.317
201709 -1.510 101.800 -1.756
201712 -3.630 101.300 -4.243
201803 -3.170 101.700 -3.691
201806 -3.590 102.300 -4.155
201809 29.960 102.400 34.641
201812 -4.250 102.100 -4.929
201903 -4.130 102.900 -4.752
201906 -4.333 102.900 -4.986
201909 -3.440 102.900 -3.958
201912 -5.420 102.900 -6.236
202003 -4.980 103.300 -5.708
202006 -1.570 103.200 -1.801
202009 -5.760 103.500 -6.589
202012 -9.680 103.400 -11.084
202103 -5.780 104.300 -6.561
202106 -6.870 105.000 -7.747
202109 -4.610 105.800 -5.159
202112 -6.490 106.600 -7.208
202203 -5.160 109.900 -5.559
202206 -11.040 113.600 -11.506
202209 -3.210 116.400 -3.265
202212 -6.740 115.900 -6.885
202303 -3.760 117.300 -3.795
202306 -5.500 116.400 -5.595
202309 1.230 117.400 1.240
202312 -4.600 116.700 -4.667
202403 -3.710 118.400 -3.710

Add all the adjusted EPS together and divide 10 will get our e10.


Zealand Pharma A/S  (CHIX:ZEALc) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Zealand Pharma A/S E10 Related Terms

Thank you for viewing the detailed overview of Zealand Pharma A/S's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Zealand Pharma A/S (CHIX:ZEALC) Business Description

Traded in Other Exchanges
Address
Sydmarken 11, Soborg, DNK, DK-2860
Zealand Pharma A/S is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. The company's product pipeline includes three product candidates in clinical development: glepaglutide, which is being developed to treat short bowel syndrome or SBS; dasiglucagon formulated for use in a dual-hormone artificial pancreas system for diabetes management; and dasiglucagon for use in the treatment of congenital hyperinsulinism. The company has out-licensed a peptide program to Boehringer Ingelheim that has been moved ahead into early clinical development: a once-weekly novel dual-acting GLP-1/glucagon agonist for the treatment of obesity and/or Type 2 diabetes.

Zealand Pharma A/S (CHIX:ZEALC) Headlines

No Headlines